The FDA position on prefilling The FDA has issued guidance discouraging healthcare facilities from prefilling syringes outside of pharmacy-controlled environments
While many of the side effects are common and mild, such as nausea, vomiting, and diarrhea, some are more severe resulting in long-term health problems
Participants in the intervention and placebo groups followed an identical 16-week dose escalation protocol, titrating up to a dose of 2.4 mg weekly or maximal tolerated dose
Insomnia and anxiety have been reported by some users
But they work through different hormonal pathways
The data presented here are from 2021, but current news points to ongoing issues of shortages and rising costs of these drugs for patients, calling for ongoing efforts to ensure appropriate and adequate access